{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:04:15Z","timestamp":1790661855299,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00738","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T08:39:31Z","timestamp":1562143171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Doxycycline for Alzheimer\u2019s Disease: Fighting \u03b2-Amyloid Oligomers and Neuroinflammation"],"prefix":"10.3389","volume":"10","author":[{"given":"Claudia","family":"Balducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1039\/C0OB00303D","article-title":"Tetracycline prevents A\u03b2 oligomer toxicity through an atypical supramolecular interaction","volume":"9","author":"Airoldi","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/jnnp-2014-309871","article-title":"A case of variably protease-sensitive prionopathy treated with doxycyclin","volume":"86","author":"Assar","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990497","article-title":"In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches","volume":"20","author":"Balducci","year":"2014","journal-title":"Curr Pharm. Des"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3233\/JAD-2010-100675","article-title":"Cognitive deficits associated with alteration of synaptic metaplasticity precede plaque deposition in AbetaPP23 transgenic mice","volume":"21","author":"Balducci","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","article-title":"Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer\u2019s disease","volume":"60","author":"Balducci","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pnpbp.2019.01.005","article-title":"Dendritic spines: revisiting the physiological role","volume":"92","author":"Chidambaram","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"41647","DOI":"10.1074\/jbc.M111.274548","article-title":"Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease","volume":"286","author":"Costa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jnr.23777","article-title":"Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer\u2019s disease","volume":"95","author":"Daulatzai","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.2174\/0929867324666170616110111","article-title":"The role of mitochondrial dysfunction in the progression of alzheimer\u2019s disease","volume":"25","author":"Desler","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","article-title":"Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer\u2019s disease","volume":"21","author":"Dineley","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.nbd.2010.07.002","article-title":"Tetracycline and its analogues protect Caenorhabditis elegans from beta amyloid-induced toxicity by targeting oligomers","volume":"40","author":"Diomede","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2012.07.002","volume":"33","author":"Drouin-Ouellet","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.26624","article-title":"Oligomeropathies and pathogenesis of Alzheimer and Parkinson\u2019s diseases","volume":"31","author":"Forloni","year":"2016","journal-title":"Mov. Disord."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4161\/pri.5.1.14367","article-title":"\u03b2-amyloid oligomers and prion protein: fatal attraction","volume":"5","author":"Forloni","year":"2011","journal-title":"Prion"},{"key":"B20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.neurobiolaging.2010.01.001","article-title":"A\u03b2 oligomers inhibit synapse remodelling necessary for memory consolidation","volume":"32","author":"Freir","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.33588\/rn.6611.2017519","article-title":"Epidemiology of Alzheimer\u2019s disease and other dementias","volume":"66","author":"Garre-Olmo","year":"2018","journal-title":"Rev. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Haik","year":"2014","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2012.10.129","article-title":"Soluble oligomers and fibrillar species of amyloid beta-peptide differentially affect cognitive functions and hippocampal inflammatory response","volume":"429","author":"He","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1471-4159.2010.06783.x","article-title":"Microglial activation depends on beta-amyloid conformation: role of the formylpeptide receptor 2","volume":"114","author":"Heurtaux","year":"2010","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nn.2785","article-title":"A\u03b2(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3\u03b2","volume":"14","author":"Jo","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease","volume":"52","author":"Loeb","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-017-0241-2","article-title":"Role of neuroinflammation in neurodegeneration: new insights","volume":"9","author":"McManus","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.02.003","article-title":"Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta","volume":"210","author":"Michelucci","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","article-title":"A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial","volume":"28","author":"Molloy","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nlm.2013.07.002","article-title":"Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research","volume":"105","author":"Morris","year":"2013","journal-title":"Neurobiol. Learn. Mem."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s Disease and aging","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jnnp-2014-310127","article-title":"Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease","volume":"86","author":"Pocchiari","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbr.2008.06.001","article-title":"Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures","volume":"193","author":"Poling","year":"2008","journal-title":"Behav. Brain Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.ai.2017.06.004","article-title":"Complement System in Neural Synapse Elimination in Development and Disease","volume":"135","author":"Presumey","year":"2017","journal-title":"Adv. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","article-title":"The neuroprotective effect of doxycycline on neurodegenerative diseases","volume":"35","author":"Santa-Cec\u00edlia","year":"2019","journal-title":"Neurotox. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004457","article-title":"Alzheimer\u2019s disease","volume":"3","author":"Selkoe","year":"2011","journal-title":"Cold Spring Harb. Perspect Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not","volume":"177","author":"Serhan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7227rev","article-title":"Resolution of inflammation: state of the art, definitions and terms","volume":"21","author":"Serhan","year":"2007","journal-title":"FASEB J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1021\/jm400161p","article-title":"A new face for old antibiotics: tetracyclines in treatment of amyloidoses","volume":"56","author":"Stoilova","year":"2013","journal-title":"J. Med. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2006.09.014","article-title":"Dendritic protein synthesis, synaptic plasticity, and memory","volume":"127","author":"Sutton","year":"2006","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J. Mol. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: a double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jnr.21998","article-title":"NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus","volume":"87","author":"Yamin","year":"2009","journal-title":"J. Neurosci. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T08:39:33Z","timestamp":1562143173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":66,"alternative-id":["10.3389\/fphar.2019.00738"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00738","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"article-number":"738"}}